Evidence map›Paper›PMID 42097663›Full record

Observational studyVox sanguinis2026

Association between NT-proBNP and false-positive Coombs test in patients with heart failure and elevated NT-proBNP.

Ana Lamilla Álvarez, María Asunción Cámara Rodenas, Sofía Russo Botero, Pau Aracil Boigues, Cristina Játiva Sáez, Elena Vidal Rico, Elena Santos Cañamares, Alma Rangel Algaba, Sebastian Ortiz-Zuluaga, Josefa Esperanza Marco Buades and 3 more

Abstract readObservational Study
In one paragraph

Observational study in Vox sanguinis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ana Lamilla ÁlvarezInternal Medicine Department, Valencia General University Hospital, Valencia, Spain.ORCID https://orcid.org/0009-0007-4642-6719
María Asunción Cámara RodenasHaematology and Haemotherapy Department, Valencia General University Hospital, Valencia, Spain.
Sofía Russo BoteroInternal Medicine Department, Valencia General University Hospital, Valencia, Spain.
Pau Aracil BoiguesCardiology Department, Valencia General University Hospital, Valencia, Spain.
Cristina Játiva SáezHaematology and Haemotherapy Department, Valencia General University Hospital, Valencia, Spain.
Elena Vidal RicoHaematology and Haemotherapy Department, Valencia General University Hospital, Valencia, Spain.
Elena Santos CañamaresHaematology and Haemotherapy Department, Valencia General University Hospital, Valencia, Spain.
Alma Rangel AlgabaHaematology and Haemotherapy Department, Valencia General University Hospital, Valencia, Spain.
Sebastian Ortiz-ZuluagaHaematology and Haemotherapy Department, Valencia General University Hospital, Valencia, Spain.
Josefa Esperanza Marco BuadesHaematology and Haemotherapy Department, Valencia General University Hospital, Valencia, Spain.
Lorenzo Fácila RubioCardiology Department, Valencia General University Hospital, Valencia, Spain.ORCID https://orcid.org/0000-0003-1402-4364
José Pérez-SilvestreInternal Medicine Department, Valencia General University Hospital, Valencia, Spain.
María de la Encarnación López-PavíaHaematology and Haemotherapy Department, Valencia General University Hospital, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe human antiglobulin test or Coombs' test is a key tool in the diagnosis and classification of haemolytic anaemia and could present as falsely positive. A retrospective study has described that B-type natriuretic peptide (NT-proBNP), a biomarker used for heart failure (HF), could be an additional cause of false positives in the Coombs test. MATERIALS AND

methodsA prospective, observational, single-centre study was conducted in adult patients diagnosed with HF between October 2024 and March 2025 at a tertiary hospital. The Coombs' test was considered as false positive in cases in which the specificity of the test included immunoglobulin G (IgG), the subsequent elution yielded a negative result, and blood haemolysis parameters were within normal ranges.

resultsThirty-six patients were included, of whom nine (25%) had a false-positive Coombs test. These patients had significantly higher levels of NT-proBNP (10,825 pg/mL [2587-35,000] vs. 3314 pg/mL [278-11,856], p = 0.0076) and lower glomerular filtration rate (35.3 mL/min/1.73 m

conclusionThe results suggest that elevated NT-proBNP could also be a cause of false positives in the Coombs test.

Indexed as

Coombs TestHeart FailureNatriuretic Peptide, BrainPeptide FragmentsAgedBiomarkersFalse Positive ReactionsFemaleHumansMaleMiddle AgedProspective StudiesBiomarkersNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)B‐type natriuretic peptidedirect antiglobulin testheart failureinterference

Identifiers

PMID42097663
PMCPMC13453913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.